Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Mobile app and AI video education to help people doing clean intermittent catheterization

Official title: Effect of Mobile Application- and Artificial Intelligence-Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Intermittent Catheterization

Run by Mersin University · NCT07489261 · Data updated 2026-11-12

A three-arm randomized trial will test whether a mobile app and an AI-supported educational video help adults who use clean intermittent catheterization to be more adherent, confident, and less affected by infections than standard training.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment99 (estimated)
SponsorMersin University
Academic / other
Locations1 site (Mersin)
StatusRecruiting
StartedApril 1, 2026
Main results expectedDecember 15, 2026
Study endsApril 1, 2027
Registry record updatedJune 24, 2026
Trial IDNCT07489261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults requiring intermittent catheterization who are Turkish-speaking, literate, own a digital device, and can use technology.

Probably not a fit

Patients who do not use or cannot access a smartphone, tablet, or computer, or who have difficulty using digital tools, may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study is a prospective, three-arm randomized controlled trial conducted at the Urology Outpatient Clinic of Mersin University. It investigates whether a mobile application and an AI-supported educational video improve adherence, perceived difficulty, and self-confidence for clean intermittent catheterization, as well as infection-related outcomes and hospitalizations. Participants will be adults (≥18) who require intermittent catheterization, are Turkish-speaking, literate, and own a suitable device. Training is currently provided via brochure, with follow-ups at 15 days and 3 months; the intervention arms add digital education tools to standard care. The study plans to enroll about 99 participants to account for potential dropouts.

Why it matters

Potential benefit: If successful, patients may experience better adherence, higher self-confidence, fewer infections, and fewer hospital visits related to catheterization.

How similar studies have gone: There is limited or no prior study using mobile apps with AI-supported videos for CIC education in this setting, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who require intermittent catheterization (TAK),
* Aged 18 years or older,
* Willing to participate in the study,
* Able to understand Turkish,
* Literate,
* Without visual or hearing impairments,
* Owning a smartphone, tablet, or computer,
* Without difficulties using technology.

Exclusion Criteria:

* Patients who do not require intermittent catheterization (TAK),
* Under 18 years of age,
* Not willing to participate in the study,
* Do not understand Turkish,
* Illiterate,
* With visual or hearing impairments,
* Do not own a smartphone, tablet, or computer,
* Having difficulties using technology.

Where it's running

  • Mersin Unıversıty
    Mersin, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Gamze Bozkul — Tarsus University
  • Study coordinator: ELİFE KETTAŞ DÖLEK, Prinicipal İnvestigator
  • Email: elifeket@yahoo.com
  • Phone: 03242410000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.